United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Healthcare Industry News Nevro’s Senza Omnia SCS system gets CE mark for chronic pain treatment US medical device company Nevro has secured CE mark approval for its Senza Omnia spinal cord stimulation system… bypharmanewsdailyMay 22, 2020
